These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 11917163)
1. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues. Liu V; McKee PH Adv Anat Pathol; 2002 Mar; 9(2):79-100. PubMed ID: 11917163 [TBL] [Abstract][Full Text] [Related]
2. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Kempf W; Dummer R; Burg G Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473 [TBL] [Abstract][Full Text] [Related]
3. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392 [TBL] [Abstract][Full Text] [Related]
4. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Kikuchi A; Nishikawa T Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520 [TBL] [Abstract][Full Text] [Related]
5. Epidermotropic CD8 positive lymphoproliferative diseases: histological and immunophenotypic similarities but markedly differing clinical behaviour. Paton DJ; Van Vliet C; Prasad Kumarasinghe S; Chan JJ; Wood BA Pathology; 2016 Dec; 48(7):733-736. PubMed ID: 27814904 [No Abstract] [Full Text] [Related]
6. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment. Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940 [TBL] [Abstract][Full Text] [Related]
7. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas. Bosisio FM; Cerroni L Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types. Kinney MC; Jones D Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828 [TBL] [Abstract][Full Text] [Related]
11. The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome. Oschlies I; King RL; Dotlic S; Montes-Moreno S; Ponzoni M; Traverse-Glehen A; Calaminici M; Ferry JA; Ott G; Goodlad JR Virchows Arch; 2020 May; 476(5):683-699. PubMed ID: 31781845 [TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II. Paulli M; Berti E Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460 [TBL] [Abstract][Full Text] [Related]
16. [Cutaneous lymphomas: new entities and rare variants]. Kempf W; Mitteldorf C Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355 [TBL] [Abstract][Full Text] [Related]